Decision Making for Urinary Diversion in Patients With Bladder Cancer
NCT05111639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52
Last updated 2025-08-14
Summary
This proposal will aim to improve the understanding about the treatment decision in the type of urinary diversion and identify patient knowledge gaps about uncertainty around patient decision-making.
Conditions
Sponsors & Collaborators
-
American Urological Association
collaborator OTHER -
University of Colorado, Denver
lead OTHER
Principal Investigators
-
Janet Kukreja · Colorado Research Center
Eligibility
- Min Age
- 18 Years
- Max Age
- 89 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-08-24
- Primary Completion
- 2025-02-21
- Completion
- 2025-02-21
Countries
- United States
Study Locations
More Related Trials
-
Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments
NCT06138561 ·Status: RECRUITING
-
Prognostic Biomarkers in Patients With Urothelial Carcinoma
NCT04872036 ·Status: COMPLETED
-
Urinary Biomarkers in the Detection of Urothelial Carcinoma of the Bladder
NCT02745301 ·Status: COMPLETED
-
Bladder Cancer Detection Using Convolutional Neural Networks
NCT05193656 ·Status: RECRUITING
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Recovery Support for Bladder Cancer Patients and Caregivers
NCT04055311 ·Status: COMPLETED ·Phase: NA
-
The Effect of Treatment on Circulating Tumor Cells in Bladder Cancer Patients With Muscle-invasive or Advanced Disease
NCT00829920 ·Status: COMPLETED
-
Combination Chemotherapy and Radiation Therapy With/Without Surgery In Patients With Stage II/III Bladder Cancer
NCT00055601 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma
NCT04812145 ·Status: UNKNOWN
-
Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children
NCT04993859 ·Status: RECRUITING
-
CISTO: Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer
NCT03933826 ·Status: ACTIVE_NOT_RECRUITING
-
Impact of COMORBIDities After Radical Cystectomy Using a Predictive Method With Artificial Intelligence
NCT05204186 ·Status: UNKNOWN
-
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
NCT07225127 ·Status: RECRUITING
-
The Impact of Late Effects After Treatment for Bladder Cancer on Quality of Life
NCT05195515 ·Status: ENROLLING_BY_INVITATION
-
Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder
NCT02968732 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers
NCT03413982 ·Status: RECRUITING
-
Bladder Cancer and Neoadjuvant Chemotherapy Efficiency Before Cystectomy
NCT06294054 ·Status: ACTIVE_NOT_RECRUITING
-
Improving Clinical Staging for Muscle Invasive Bladder Cancer Through Molecular Profiling and Improved Imaging
NCT02203136 ·Status: COMPLETED
-
Bladder Cancer Patient-Reported Outcomes
NCT01090388 ·Status: COMPLETED
-
Ileal Conduit Versus Cutaneous Ureterostomy After Radical Cystectomy
NCT04610385 ·Status: UNKNOWN
-
Urinary Diversion During Robotic Assisted Radical Cystectomy in Patients With Bladder Cancer
NCT02252393 ·Status: WITHDRAWN ·Phase: NA
-
Markers of Response to Intravesical Bladder Cancer Therapy
NCT01007058 ·Status: COMPLETED
-
A Diagnostic for the Early Detection of Bladder Cancer
NCT05347342 ·Status: ACTIVE_NOT_RECRUITING
-
Exploring Engagement Dynamics Among Individuals Impacted by Bladder Cancer
NCT06009510 ·Status: NOT_YET_RECRUITING